FREQUENT BASELINE EGFR MUTATION T790M IN CYTOLOGICAL SPECIMENS OF TYROSINE KINASE INHIBITOR (TKI) NAIVE ADENOCARCINOMA NSCLC PATIENTS

被引：0

作者：

Andarini, S. L. ^{[1
]}

Zaini, J. ^{[1
]}

Hudoyo, A. ^{[1
]}

Hidayat, H. ^{[1
]}

Widjajahakim, G. ^{[2
]}

Utomo, A. R. ^{[3
]}

机构：

[1] Univ Indonesia, Persahabatan Hosp, Dept Pulmonol & Resp Med, Fac Med, Jakarta, Indonesia

[2] KalGen Lab, Pathol Core Facil, Jakarta, Indonesia

[3] KalGen Lab, Stem Cell & Canc Inst, Canc Diagnost Res, Jakarta, Indonesia

来源：

RESPIROLOGY | 2016年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

APSR6-0587

引用

页码：79 / 79

页数：1

共 50 条

[21] EGFR T790M detection in TKI-naive NSCLCs carrying sensitive EGFR mutations
Pinotti, G.
Cerutti, R.
Sahnane, N.
Lettig, L.
Albeni, C.
Tuzi, A.
Franzi, F.
Pastore, A.
Ogliari, F.
Sessa, F.
Furlan, D.
ANNALS OF ONCOLOGY, 2017, 28
[22] Clinical Impact of Pretreatment EGFR T790M Mutation in Lung Adenocarcinoma Patients
Macerola, Elisabetta
Bruno, Rossella
Prediletto, Irene
Sensi, Elisa
Chella, Antonio
Landi, Lorenza
Ali, Greta
Fontanini, Gabriella
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1207 - S1207
[23] Therapy for EGFR tyrosine kinase inhibitor-resistant NSCLC with a focus on the T790M-resistant mutation
Zabernigg A.
memo - Magazine of European Medical Oncology, 2016, 9 (4) : 187 - 190
[24] The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma
Zhang, Qiuyi
Ke, Ee
Niu, Feiyu
Deng, Wei
Chen, Zhihong
Xu, Chongrui
Zhang, Xuchao
Zhao, Ning
Su, Jian
Yang, Jinji
Yan, Honghong
Wu, Yilong
Zhou, Qing
ONCOTARGET, 2017, 8 (03) : 4994 - 5002
[25] Spatiotemporal T790M heterogeneity in individual patients with non-small cell lung cancer (NSCLC) after acquired resistance to EGFR-tyrosine kinase inhibitor (TKI)
Hata, Akito
Katakami, Nobuyuki
Yoshioka, Hiroshige
Masago, Katsuhiro
Fujita, Shiro
Imai, Yukihiro
Tomii, Keisuke
Nishiyama, Akihiro
Ishida, Tadashi
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[26] T790M mutation and c-MET amplification might be correlated to TTP of EGFR-TKI in NSCLC
Wu, Y.
Mok, T. S.
Chen, H.
Zhang, X.
Guo, A.
Jaenne, P. A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[27] Noninvasive detection of acquired T790M mutation in NSCLC patients treated with EGFR-TKI using digital PCR of plasma
Ishii, Hidenobu
Azuma, Koichi
Sakai, Kazuko
Tokito, Takaaki
Yamada, Kazuhiko
Nishio, Kazuto
Hoshibo, Tomoaki
ANNALS OF ONCOLOGY, 2015, 26 : 138 - 138
[28] Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M
Zhao, Sha
Li, Xuefei
Zhao, Chao
Jiang, Tao
Jia, Yijun
Shi, Jinpeng
He, Yayi
Li, Jiayu
Zhou, Fei
Gao, Guanghui
Li, Wei
Chen, Xiaoxia
Su, Chunxia
Ren, Shengxiang
Zhou, Caicun
LUNG CANCER, 2019, 128 : 33 - 39
[29] Assessment of Clinical Usability of a cfDNA-Based Assay Detecting EGFR T790M Mutation in EGFR-TKI Refractory NSCLC Patients
Hanibuchi, Masaki
Kanoh, Akira
Kuramoto, Takuya
Goto, Hisatsugu
Saijo, Atsuro
Ogino, Hirokazu
Nishioka, Yasuhiko
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1258 - S1259
[30] Detection of the T790M Mutation of EGFR in Plasma of Advanced NSCLC Patients with Acquired Resistance to EGFR-TKI (WJOG8014LTR)
Azuma, Koichi
Takahama, Takayuki
Sakai, Kazuko
Takeda, Masayuki
Hida, Toyoaki
Hirabayashi, Masataka
Oguri, Tetsuya
Tanaka, Hiroshi
Ebi, Noriyuki
Sawa, Toshiyuki
Bessho, Akihiro
Tachihara, Motoko
Akamatsu, Hiroaki
Bandoh, Shuji
Himeji, Daisuke
Ohira, Tatsuo
Shimokawa, Mototsugu
Yamamoto, Nobuyuki
Nakanishi, Yoichi
Nakagawa, Kazuhiko
Nishio, Kazuto
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S389 - S390

← 1 2 3 4 5 →